584 results on '"Jandrot-Perrus, Martine"'
Search Results
2. De l’identification d’un récepteur plaquettaire (GPVI) au développement d’un candidat antiplaquettaire découplé du risque hémorragique
3. Exacerbation of thromboinflammation by JAK2V617F mutation worsens the prognosis of cerebral venous sinus thrombosis
4. Safety and efficacy of platelet glycoprotein VI inhibition in acute ischaemic stroke (ACTIMIS): a randomised, double-blind, placebo-controlled, phase 1b/2a trial
5. Glycoprotein VI interplay with fibrin(ogen) in thrombosis
6. Targeting platelet GPVI with glenzocimab: a novel mechanism for inhibition
7. Amplified inhibition of atherosclerotic plaque-induced platelet activation by glenzocimab with dual antiplatelet therapy
8. Respective roles of Glycoprotein VI and FcγRIIA in the regulation of αIIbβ3‐mediated platelet activation to fibrinogen, thrombus buildup, and stability
9. Selective inhibition of carboxypeptidase U may reduce microvascular thrombosis in rat experimental stroke
10. Aspirine en prévention primaire : risque de l'arrêt.
11. Targeting GPVI with glenzocimab in COVID-19 patients: Results from a randomized clinical trial.
12. Validation of the ISTH/SSC bleeding assessment tool for inherited platelet disorders: A communication from the Platelet Physiology SSC
13. High factor VIII concentrations interfere with glycoprotein VI-mediated platelet activation in vitro
14. Safety and efficacy of platelet glycoprotein VI inhibition in acute ischaemic stroke (ACTIMIS): a randomised, double-blind, placebo-controlled, phase 1b/2a trial
15. GPVI
16. A mutation of the human EPHB2 gene leads to a major platelet functional defect
17. Quality and cost assessment of a recombinant antibody fragment produced from mammalian, yeast and prokaryotic host cells: A case study prior to pharmaceutical development
18. Association between endometriosis, infertility and autoimmune antiplatelet glycoprotein VI antibodies in two patients.
19. Pharmacological Blockade of Glycoprotein VI Promotes Thrombus Disaggregation in the Absence of Thrombin
20. Acute ischemic stroke thrombi have an outer shell that impairs fibrinolysis
21. Safety and Tolerability, Pharmacokinetics, and Pharmacodynamics of ACT017, an Antiplatelet GPVI (Glycoprotein VI) Fab: First-in-Human Healthy Volunteer Trial
22. Pharmacological Inhibition of Glycoprotein VI- and Integrin α2β1-Induced Thrombus Formation Modulated by the Collagen Type
23. Single platelets seal neutrophil-induced vascular breaches via GPVI during immune-complex–mediated inflammation in mice
24. Platelet glycoprotein VI binds to polymerized fibrin and promotes thrombin generation
25. Targeting platelet GPVI with glenzocimab: a novel mechanism for inhibition
26. Platelets favor the outgrowth of established metastases
27. Coagulation Factor XIIIa and Activated Protein C Activate Platelets via GPVI and PAR1
28. Increased expression of protease nexin-1 in fibroblasts during idiopathic pulmonary fibrosis regulates thrombin activity and fibronectin expression
29. New advances in treating thrombotic diseases: GPVI as a platelet drug target
30. Microfluidic Modeling of Thrombolysis: Effect of Antiplatelet and Anticoagulant Agents on tPA (Tissue-Type Plasminogen Activator)-Induced Fibrinolysis
31. Protease‐activated receptor 1 inhibition protects mice against thrombin‐dependent respiratory syncytial virus and human metapneumovirus infections
32. High thrombus platelet content is associated with a lower rate of first pass effect in stroke treated by endovascular therapy
33. Glenzocimab does not impact glycoprotein VI-dependent inflammatory hemostasis
34. Exacerbation of Thromboinflammation by Hyperglycemia Precipitates Cerebral Infarct Growth and Hemorrhagic Transformation
35. Protease nexin-1 regulates retinal vascular development
36. Emerging role of serpinE2/protease nexin-1 in hemostasis and vascular biology
37. GPVI and collagen: the final word?
38. Switch from protective to adverse inflammation during influenza: viral determinants and hemostasis are caught as culprits
39. Histopathological evaluation of thrombus in patients presenting with stent thrombosis. A multicenter European study: a report of the prevention of late stent thrombosis by an interdisciplinary global European effort consortium†
40. Anticoagulant and antithrombotic properties of platelet protease nexin-1
41. Detection of endogenous tissue factor levels in plasma using the calibrated automated thrombogram assay
42. Distinct spatio-temporal Ca2+ signaling elicited by integrin α2β1 and glycoprotein VI under flow
43. Alteplase Reduces Downstream Microvascular Thrombosis and Improves the Benefit of Large Artery Recanalization in Stroke
44. Platelet Activation and Aggregation Promote Lung Inflammation and Influenza Virus Pathogenesis
45. Characterization of a novel dermatan sulfate with high antithrombin activity from ray skin ( Raja radula)
46. Mechanism of thrombin inhibition by heparin cofactor II and antithrombin in the presence of the ray ( Raja radula) skin dermatan sulfate
47. De l'identification d'un récepteur plaquettaire, la glycoprotéine VI, au développement d'un candidat antiplaquettaire dénué de risque hémorragique.
48. Intravenous abciximab as a rescue therapy for immediate reocclusion after successful mechanical thrombectomy in acute ischemic stroke patients
49. Interferon Alpha Therapy Increases Pro-Thrombotic Biomarkers in Patients with Myeloproliferative Neoplasms
50. Roles of the C-terminal tyrosine residues of LAT in GPVI-induced platelet activation: insights into the mechanism of PLCγ2 activation
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.